Curative Biosciences Stock Net Income
| CBDX Stock | USD 0.0002 0.00 0.00% |
As of the 4th of March, Curative Biosciences shows the Standard Deviation of 18.46, mean deviation of 5.92, and Risk Adjusted Performance of 0.1021. Curative Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Curative Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Curative Biosciences' valuation are provided below:Curative Biosciences does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Curative |
Curative Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Curative Biosciences' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Curative Biosciences.
| 12/04/2025 |
| 03/04/2026 |
If you would invest 0.00 in Curative Biosciences on December 4, 2025 and sell it all today you would earn a total of 0.00 from holding Curative Biosciences or generate 0.0% return on investment in Curative Biosciences over 90 days. Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol More
Curative Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Curative Biosciences' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Curative Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1207 | |||
| Maximum Drawdown | 150.0 |
Curative Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Curative Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Curative Biosciences' standard deviation. In reality, there are many statistical measures that can use Curative Biosciences historical prices to predict the future Curative Biosciences' volatility.| Risk Adjusted Performance | 0.1021 | |||
| Jensen Alpha | 2.25 | |||
| Total Risk Alpha | 1.42 | |||
| Treynor Ratio | 8.07 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Curative Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Curative Biosciences March 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1021 | |||
| Market Risk Adjusted Performance | 8.08 | |||
| Mean Deviation | 5.92 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 18.46 | |||
| Variance | 340.91 | |||
| Information Ratio | 0.1207 | |||
| Jensen Alpha | 2.25 | |||
| Total Risk Alpha | 1.42 | |||
| Treynor Ratio | 8.07 | |||
| Maximum Drawdown | 150.0 | |||
| Skewness | 4.34 | |||
| Kurtosis | 24.43 |
Curative Biosciences Backtested Returns
Curative Biosciences appears to be out of control, given 3 months investment horizon. Curative Biosciences secures Sharpe Ratio (or Efficiency) of 0.0569, which signifies that the company had a 0.0569 % return per unit of risk over the last 3 months. By analyzing Curative Biosciences' technical indicators, you can evaluate if the expected return of 0.82% is justified by implied risk. Please makes use of Curative Biosciences' Standard Deviation of 18.46, risk adjusted performance of 0.1021, and Mean Deviation of 5.92 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Curative Biosciences holds a performance score of 4. The firm shows a Beta (market volatility) of 0.28, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Curative Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Curative Biosciences is expected to be smaller as well. Please check Curative Biosciences' information ratio and rate of daily change , to make a quick decision on whether Curative Biosciences' price patterns will revert.
Auto-correlation | -0.2 |
Insignificant reverse predictability
Curative Biosciences has insignificant reverse predictability. Overlapping area represents the amount of predictability between Curative Biosciences time series from 4th of December 2025 to 18th of January 2026 and 18th of January 2026 to 4th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Curative Biosciences price movement. The serial correlation of -0.2 indicates that over 20.0% of current Curative Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.2 | |
| Spearman Rank Test | 0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Curative Biosciences reported net income of (53,195). This is 100.02% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 100.01% higher than that of the company.
Curative Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Curative Biosciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Curative Biosciences could also be used in its relative valuation, which is a method of valuing Curative Biosciences by comparing valuation metrics of similar companies.Curative Biosciences is currently under evaluation in net income category among its peers.
Curative Fundamentals
| Return On Asset | -38.44 | |||
| Current Valuation | 9.68 M | |||
| Shares Outstanding | 31.57 M | |||
| Shares Owned By Insiders | 76.24 % | |||
| EBITDA | (50.35 K) | |||
| Net Income | (53.2 K) | |||
| Cash And Equivalents | 982 | |||
| Total Debt | 156.45 K | |||
| Book Value Per Share | (0.04) X | |||
| Cash Flow From Operations | (12.8 K) | |||
| Earnings Per Share | (0.03) X | |||
| Beta | 8.19 | |||
| Market Capitalization | 10.56 M | |||
| Total Asset | 2.27 K | |||
| Z Score | -32.4 | |||
| Net Asset | 2.27 K |
About Curative Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Curative Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Curative Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Curative Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Curative Pink Sheet Analysis
When running Curative Biosciences' price analysis, check to measure Curative Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biosciences is operating at the current time. Most of Curative Biosciences' value examination focuses on studying past and present price action to predict the probability of Curative Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biosciences' price. Additionally, you may evaluate how the addition of Curative Biosciences to your portfolios can decrease your overall portfolio volatility.